Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Pangea Bio
Pangea Bio develops small-molecule therapeutics for neurological and neuropsychiatric disorders by mining nature’s chemical space and human ethnobotanical evidence. The company combines AI-driven…
Pangea Bio
Pangea Bio develops small-molecule therapeutics for neurological and neuropsychiatric disorders by mining nature’s chemical space and human ethnobotanical evidence. The company combines AI-driven…
TL;DR
Founded: 2021
Headquarters: London, England, United Kingdom
Focus: AI-driven, nature-inspired therapeutics for neurological and neuropsychiatric disorders
Lead asset: OT-003 (planned Phase 1 in 2025)
Team size (reported): 11–50 employees
Company Overview
Problem Domain
Neurological and neuropsychiatric disorders; central nervous system (CNS) therapeutics.
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
Crunchbase lists a Series A on this date with multiple participating investors.
Last funding date reported in company snapshot metadata.
Investor Signal
“Empath Ventures, Eretz.bio, Globivest, Kadmos Capital, No Label Ventures, Seaside Ventures”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week